These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 10213365)

  • 21. Characterization of Mucosal Disaccharidases from Human Intestine.
    Amiri M; Naim HY
    Nutrients; 2017 Oct; 9(10):. PubMed ID: 28994704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolism of vasopressin, oxytocin, and their analogues in the human gastrointestinal tract.
    Fjellestad-Paulsen A; Söderberg-Ahlm C; Lundin S
    Peptides; 1995; 16(6):1141-7. PubMed ID: 8532599
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peptide hydrolases in the bruch border and soluble fractions of small intestinal mucosa of rat and man.
    Kim YS; Birtwhistle W; Kim YW
    J Clin Invest; 1972 Jun; 51(6):1419-30. PubMed ID: 5024039
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peptide hydrolases of the human small intestinal mucosa: distribution of activities between brush border membranes and cytosol.
    Sterchi EE; Woodley JF
    Clin Chim Acta; 1980 Mar; 102(1):49-56. PubMed ID: 6993048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural and conformational requirements for human calcitonin activity: design, synthesis, and study of lactam-bridged analogues.
    Kapurniotu A; Taylor JW
    J Med Chem; 1995 Mar; 38(5):836-47. PubMed ID: 7877149
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kinetic characterization of brush border membrane proteases in relationship to mucosal architecture by section biochemistry.
    Gutschmidt S; Hoper R; Gossrau R
    Adv Exp Med Biol; 1984; 167():209-18. PubMed ID: 6369906
    [No Abstract]   [Full Text] [Related]  

  • 27. NMR characterization of monomeric and oligomeric conformations of human calcitonin and its interaction with EGCG.
    Huang R; Vivekanandan S; Brender JR; Abe Y; Naito A; Ramamoorthy A
    J Mol Biol; 2012 Feb; 416(1):108-20. PubMed ID: 22200484
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of biological assay conditions on stability assessment of radiometal-labelled peptides exemplified using a 177Lu-DOTA-minigastrin derivative.
    Ocak M; Helbok A; von Guggenberg E; Ozsoy Y; Kabasakal L; Kremser L; Decristoforo C
    Nucl Med Biol; 2011 Feb; 38(2):171-9. PubMed ID: 21315272
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-performance liquid chromatography/tandem mass spectrometry identification of salmon calcitonin degradation products in aqueous solution preparations.
    Silvestro L; Savu SR
    Rapid Commun Mass Spectrom; 1996; 10(2):151-6. PubMed ID: 8616264
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced potency of human calcitonin when fibrillation is avoided.
    Cudd A; Arvinte T; Das RE; Chinni C; MacIntyre I
    J Pharm Sci; 1995 Jun; 84(6):717-9. PubMed ID: 7562410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Permeation and pathways of human calcitonin (hCT) across excised bovine nasal mucosa.
    Lang S; Rothen-Rutishauser B; Perriard JC; Schmidt MC; Merkle HP
    Peptides; 1998; 19(3):599-607. PubMed ID: 9533651
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Controlling the self-assembly of human calcitonin: a theoretical approach using molecular dynamics simulations.
    Paul S; Paul S
    Phys Chem Chem Phys; 2021 Jul; 23(26):14496-14510. PubMed ID: 34184696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heme prevents highly amyloidogenic human calcitonin (hCT) aggregation: A potential new strategy for the clinical reuse of hCT.
    Ye H; Zhou J; Li H; Gao Z
    J Inorg Biochem; 2019 Jul; 196():110686. PubMed ID: 31003065
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inactivation of atrial natriuretic factor by the renal brush border.
    Olins GM; Spear KL; Siegel NR; Zurcher-Neely HA
    Biochim Biophys Acta; 1987 Jul; 901(1):97-100. PubMed ID: 2954587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Side-chain lactam-bridge conformational constraints differentiate the activities of salmon and human calcitonins and reveal a new design concept for potent calcitonin analogues.
    Taylor JW; Jin QK; Sbacchi M; Wang L; Belfiore P; Garnier M; Kazantzis A; Kapurniotu A; Zaratin PF; Scheideler MA
    J Med Chem; 2002 Feb; 45(5):1108-21. PubMed ID: 11855991
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of calcium ions on human calcitonin. Possible implications for bone resorption by osteoclasts.
    Meleleo D; Picciarelli V
    Biometals; 2016 Feb; 29(1):61-79. PubMed ID: 26596282
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral absorption of peptides: the effect of absorption site and enzyme inhibition on the systemic availability of metkephamid.
    Langguth P; Merkle HP; Amidon GL
    Pharm Res; 1994 Apr; 11(4):528-35. PubMed ID: 8058610
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Colon-specific 9-aminocamptothecin-HPMA copolymer conjugates containing a 1,6-elimination spacer.
    Gao SQ; Lu ZR; Petri B; Kopečková P; Kopeček J
    J Control Release; 2006 Jan; 110(2):323-331. PubMed ID: 16290118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quality analysis of salmon calcitonin in a polymeric bioadhesive pharmaceutical formulation: sample preparation optimization by DOE.
    D'Hondt M; Van Dorpe S; Mehuys E; Deforce D; DeSpiegeleer B
    J Pharm Biomed Anal; 2010 Dec; 53(4):939-45. PubMed ID: 20655159
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amino acid sequence and biological activity of a calcitonin-like diuretic hormone (DH31) from Rhodnius prolixus.
    Brugge VA; Schooley DA; Orchard I
    J Exp Biol; 2008 Feb; 211(Pt 3):382-90. PubMed ID: 18203994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.